CLINICAL_TRIALS
trial_result
· 2021-03-09
Clinical Trial Update: Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patients [Phase 3]
Summary
Phase 3 trial update for AMG 334 in adults with episodic migraine reports results; completed study with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Episodic Migraine | Phase 3 | Status: COMPLETED | Results posted: 2021-03-09